Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 142.50M P/E - EPS this Y 2.30% Ern Qtrly Grth -
Income -56.61M Forward P/E -2.19 EPS next Y 16.40% 50D Avg Chg -57.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -61.00%
Dividend N/A Price/Book 0.58 EPS next 5Y - 52W High Chg -78.00%
Recommedations 2.70 Quick Ratio 29.29 Shares Outstanding 44.65M 52W Low Chg 25.00%
Insider Own 2.56% ROA -17.89% Shares Float 14.26M Beta 3.98
Inst Own 84.08% ROE -25.55% Shares Shorted/Prior 401.68K/585.45K Price 3.27
Gross Margin - Profit Margin - Avg. Volume 676,364 Target Price 5.25
Oper. Margin - Earnings Date Mar 9 Volume 365,034 Change -4.66%
About Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors. The company also develops THE-349, a fourth-generation selective epidermal growth factor receptor inhibitor to address C797X-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. As of February 14, 2024, Theseus Pharmaceuticals, Inc. operates as a subsidiary of Concentra Biosciences, LLC.

THRX Chatroom

User Image kuda8 Posted - 09/25/24

$THRX end of game , got 0,0069€ per share !

User Image NVDAMillionaire Posted - 3 months ago

$THRX Theseus Pharmaceuticals, Inc. (NASDAQ:THRX): Navigating the Challenges of Targeted Oncology Development http://beyondspx.com/2024/08/05/theseus-pharmaceuticals-inc-nasdaqthrx-navigating-the-challenges-of-targeted-oncology-development/

User Image Delta_Trader_ Posted - 9 months ago

$MCRB Tang also increased their holding of $THRX before the buyout… I will add to my position next week https://www.fiercebiotech.com/biotech/concentra-scores-another-win-theseus-agrees-buyout-offer

User Image slowasturtle Posted - 9 months ago

$THRX waht happens if I don't take the offer?

User Image Ninja_Tradez Posted - 9 months ago

📢 $THRX -Theseus Pharmaceuticals Announces Closing of Tender Offer https://newsfilter.io/a/2787073690c97e6a21fc21dd86d4c7cd

User Image Stock_Titan Posted - 9 months ago

$THRX Theseus Pharmaceuticals Announces Closing of Tender Offer https://www.stocktitan.net/news/THRX/theseus-pharmaceuticals-announces-closing-of-tender-x95ssvy6w1t6.html

User Image Mergerbrief Posted - 9 months ago

$THRX/Concentra Biosciences - Expected Completion Mergerbrief.com

User Image tradethehalt Posted - 9 months ago

$THRX trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $4.08 Vol: 3.12M.

User Image cctranscripts Posted - 10 months ago

Concentra MERGER SUB just provided an update on activist position in Theravance https://www.conferencecalltranscripts.org/summary/?id=12862628 $THRX

User Image cctranscripts Posted - 10 months ago

Solicitation, recommendation statements https://www.conferencecalltranscripts.org/summary/?id=12856766 $THRX

User Image cctranscripts Posted - 10 months ago

Theravance just filed its Tender offer statement by Third Party http://www.sec.gov/Archives/edgar/data/1745020/000114036124001546/0001140361-24-001546-index.htm $THRX

User Image EarningsInsider Posted - 12/29/23

Theseus Pharmaceuticals Sees Short Interest Decrease from 1,620,000 shares to 936,000 shares. $THRX https://www.marketbeat.com/stocks/NASDA

User Image StockAutomatePro Posted - 12/29/23

$THRX The chart shows the stock may be headed for a boost. We alerted the BUY signal at $3.81 and we were able to close this one with profit at $4.18 🎯 See more details at StockAutomate.com

User Image cctranscripts Posted - 12/28/23

Concentra Biosciences, LLC just provided an update on activist position in Theravance https://www.conferencecalltranscripts.org/summary/?id=12825548 $THRX

User Image cctranscripts Posted - 12/27/23

OrbiMed Genesis GP LLC just provided an update on activist position in Theravance https://www.conferencecalltranscripts.org/summary/?id=12824216 $THRX

User Image JillBrown124 Posted - 12/26/23

$BTCT $ALLO $ATNM $THRX ✅ If you really want to make huge profits on trading then, highly recommended for you.,💖 top-stocks-winning-great-us.blogspot.com/2023/11/blog-post.html

User Image tickeron Posted - 12/24/23

A.I.dvisor made a bullish call on $THRX, netting in a 12.33% gain over 2 days https://srnk.us/go/4950258

User Image ajobst Posted - 12/23/23

$AUPH so the sale of $THRX was just announced, with a CVR associated with the potential sale of parts of their pipeline that the acquiring company did not want. Is it possible that something similar is going on with AUPH and AUR 200? Is AUR 200 easier to spin off with the IND application filed?

User Image ajobst Posted - 12/23/23

$THRX Any idea what the CVR could be worth? Market doesn't seem to think it's worth much. Debating whether to sell now, or hold through the merger to get the CVR. Tiny position for me...I'll probably just wait...a couple of months is no biggie for maybe another $0.10+/share.

User Image ChartMill Posted - 10 months ago

$THRX: Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra https://www.chartmill.com/stock/quote/THRX/news?utm_source=prnews-2023-12-22-shareholder-alert-ademi-llp-investigates-whether-theseus-pharmaceuticals-inc-has-obtained-a-fair-price-in-its-transaction-with-concentra&utm_medium=stocktwits&utm_campaign=pressRelease

User Image swingingtech Posted - 10 months ago

$THRX https://wallstreetwaves.com/small-cap-cancer-focused-theseus-pharmaceuticals-goes-private-for-over-3-90-share-in-cash/

User Image OpenOutcrier Posted - 10 months ago

$THRX (+7.6% pre) Theseus Pharmaceuticals (THRX) Acquired by Concentra Biosciences for $3.90-$4.05/sh Cash Plus CVR - SI https://ooc.bz/l/20530

User Image RonFarms Posted - 10 months ago

$THRX watch inbs...

User Image Market_Max Posted - 10 months ago

$TECX Check out the $THRX story line. Very interesting. Just got bought out for cash plus CVR. Patiently waiting for AVRO.

User Image ChartMill Posted - 10 months ago

$THRX: Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right https://www.chartmill.com/stock/quote/THRX/news?utm_source=prnews-2023-12-22-theseus-pharmaceuticals-enters-into-agreement-to-be-acquired-by-concentra-biosciences-for-between-390-and-405-in-cash-per-share-plus-a-contingent-value-right&utm_medium=stocktwits&utm_campaign=pressRelease

User Image cctranscripts Posted - 10 months ago

Written communication relating to third party tender offer https://www.conferencecalltranscripts.org/summary/?id=12817231 $THRX

User Image cctranscripts Posted - 10 months ago

Theravance: Theseus Pharmaceuticals Enters Into Agreement To Be Acquired By Concentra Bioscienc https://www.conferencecalltranscripts.org/summary/?id=12817212 $THRX

User Image Last10K Posted - 10 months ago

$THRX just filed with the SEC a New Agreement, a Ending Agreement, a Event for Officers, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/THRX/0001104659-23-128468.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=THRX

User Image DonCorleone77 Posted - 10 months ago

$THRX 2 of 2 - Theseus Pharmaceuticals to be acquired by Concentra for $3.90-$4.05 per share ...the acquisition by Concentra - of which Tang Capital Partners is the controlling shareholder - is in the best interests of all Theseus shareholders, and has unanimously approved the merger agreement. Pursuant and subject to the terms of the merger agreement, a wholly owned subsidiary of Concentra will commence a tender offer by January 9 to acquire all outstanding shares of Theseus common stock. Closing of the offer is subject to certain conditions, including the tender of Theseus common stock representing at least a majority of the total number of outstanding shares; the availability of at least $187.6M of cash, net of transaction costs, wind-down costs and other liabilities, at closing, and other customary closing conditions. Theseus shareholders holding approximately 59% of Theseus common stock have signed support agreements under which such shareholders agreed to tender....

User Image DonCorleone77 Posted - 10 months ago

$THRX 1 of 2 - Theseus Pharmaceuticals to be acquired by Concentra for $3.90-$4.05 per share Theseus Pharmaceuticals announced it has entered into a definitive merger agreement whereby Concentra Biosciences will acquire Theseus for a price per share of Theseus common stock of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an additional cash amount of not more than 15c per share at the closing of the merger, plus one non-tradeable contingent value right, or CVR, representing the right to receive 80% of the net proceeds from any license or disposition of Theseus' programs effected within 180 days of closing of the merger and 50% of the potential aggregate value of certain specified potential cost savings realized within 180 days of the close of the merger, pursuant to a CVR agreement. Following a thorough review process conducted with the assistance of its legal and financial advisors, Theseus' board of directors has determined that....

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Foresite Capital Management V,... 10% Owner 10% Owner Jul 17 Buy 2.97 700,000 2,079,000 1,385,825 07/19/23
HAYDEN DONALD J JR Director Director Dec 29 Buy 5 10,000 50,000 10,000 01/03/23
GORDON CARL L Director Director Jan 19 Buy 9.96 158,417 1,577,833 16,542,652 01/21/22
ORBIMED ADVISORS LLC Director Director Jan 19 Buy 9.96 158,417 1,577,833 16,542,652 01/21/22
GORDON CARL L Director Director Jan 11 Buy 9.99 44,717 446,723 16,384,235 01/13/22
ORBIMED ADVISORS LLC Director Director Jan 11 Buy 9.99 44,717 446,723 16,384,235 01/13/22
GORDON CARL L Director Director Oct 12 Buy 16 625,000 10,000,000 499,150 10/14/21
Rock Springs Capital Managemen... 10% Owner 10% Owner Oct 12 Buy 16 250,000 4,000,000 599,320 10/14/21
ORBIMED ADVISORS LLC Director Director Oct 12 Buy 16 625,000 10,000,000 499,150 10/14/21